Subclinical thyroid dysfunction and fracture risk a meta-analysis

JAMA - Journal of the American Medical Association

Volumn 313, Issue 20, 2015, Pages 2055-2065

  Blum, Manuel R ^a   Bauer, Douglas C ^b   Collet, Tinh Hai ^c   Fink, Howard A ^d,e   Cappola, Anne R ^f   Da Costa, Bruno R ^g   Wirth, Christina D ^a   Peeters, Robin P ^h   Asvold, Bjorn O ^i,j   Den Elzen, Wendy P J ^k   Luben, Robert N ^l   Imaizumi, Misa ^m   Bremner, Alexandra P ⁿ   Gogakos, Apostolos ^o   Eastell, Richard ^p   Kearney, Patricia M ^q   Strotmeyer, Elsa S ^r   Wallace, Erin R ^s   Hoff, Mari ^i,t   Ceresini, Graziano ^u   Rivadeneira, Fernando ^h   Uitterlinden, Andre G ^h   Stott, David J ^v   Westendorp, Rudi G J ^w   Khaw, Kay Tee ^l   Langhammer, Arnuf ⁱ   Ferrucci, Luigi ^x   Gussekloo, Jacobijn ^k   Williams, Graham R ^o   Walsh, John P ^y,z   Juni, Peter ^aa   Aujesky, Drahomir ^a   Rodondi, Nicolas ^a   more..

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g FLORIDA INTERNATIONAL UNIVERSITY   (United States)

^h ERASMUS MEDICAL CENTER   (Netherlands)

ⁱ NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^j TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^k LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^l UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^m RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

ⁿ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^o IMPERIAL COLLEGE LONDON   (United Kingdom)

^p UNIVERSITY OF SHEFFIELD   (United Kingdom)

^q UNIVERSITY COLLEGE CORK   (Ireland)

^r UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^s UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^t Levanger hospital   (Norway)

^u UNIVERSITY HOSPITAL OF PARMA   (Italy)

^v UNIVERSITY OF GLASGOW   (United Kingdom)

^w UNIVERSITY OF COPENHAGEN   (Denmark)

^x NATIONAL INSTITUTE ON AGING   (United States)

^y UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^z SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^aa UNIVERSITY OF BERN   (Switzerland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

ADULT; ARTICLE; AUSTRALIA; BONE FRAGILITY; BONE RADIOGRAPHY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPE; EUTHYROIDISM; FEMALE; HIP FRACTURE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; NONSPINE FRACTURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SPINE FRACTURE; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; SUBCLINICAL THYROID DYSFUNCTION; THYROID DISEASE; THYROID FUNCTION; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; UNITED STATES; ADOLESCENT; AGED; BLOOD; COMPLICATION; FRACTURES, BONE; HIP FRACTURES; HYPERTHYROIDISM; HYPOTHYROIDISM; MIDDLE AGED; SPINAL FRACTURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FRACTURES, BONE; HIP FRACTURES; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; RISK FACTORS; SPINAL FRACTURES; THYROTROPIN; YOUNG ADULT;

EID: 84929913365     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.5161     Document Type: Article

References (59)

1. Vestergaard P, Mosekilde L. Hyperthyroidism, bone mineral, and fracture risk-a meta-analysis. Thyroid. 2003;13(6):585-593.
2. Bassett JH, Williams GR. Critical role of the hypothalamic-pituitary-thyroid axis in bone. Bone. 2008;43(3):418-426.
3. Bauer DC, Ettinger B, Nevitt MC, Stone KL; Study of Osteoporotic Fractures Research Group. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med. 2001;134(7):561-568.
4. Nicholls JJ, Brassill MJ, Williams GR, Bassett JH. The skeletal consequences of thyrotoxicosis. J Endocrinol. 2012;213(3):209-221.
5. Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010;95(1):186-193.
6. Finigan J, Greenfield DM, Blumsohn A, et al. Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in women. J Bone Miner Res. 2008;23(1):75-85.
7. Waring AC, Harrison S, Fink HA, et al. A prospective study of thyroid function, bone loss, and fractures in older men: theMrOS study. J Bone Miner Res. 2013;28(3):472-479.
8. Lee JS, Buzkova P, Fink HA, et al. Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med. 2010;170(21):1876-1883.
9. Wirth CD, BlumMR, da Costa BR, et al. Subclinical thyroid dysfunction and the risk for fractures: a systematic review and meta-analysis. Ann Intern Med. 2014;161(3):189-199.
10. Simmonds MC, Higgins JP, Stewart LA, Tierney JF, ClarkeMJ, Thompson SG. Meta-analysis of individual patient data from randomized trials: a review ofmethods used in practice. Clin Trials. 2005;2(3):209-217.
11. Cardiovascular Health Study-National Heart, Lung, and Blood Institute. The Cardiovascular Health Study. https://chs-nhlbi.org/. Accessed January 7, 2015.
12. Rodondi N, den ElzenWP, Bauer DC, et al; Thyroid Studies Collaboration. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-1374.
13. BMJ Clinical Evidence. Search filters (Medline cohort study filter): ClinicalEvidence website; 2013. http://clinicalevidence.bmj.com/x/set/static/ebm/learn/665076.html. Accessed May 5, 2015.
14. Collet TH, Gussekloo J, Bauer DC, et al; Thyroid Studies Collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172(10):799-809.
15. Gencer B, Collet TH, Virgini V, et al; Thyroid Studies Collaboration. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation. 2012;126(9):1040-1049.
16. Collet TH, Bauer DC, Cappola AR, et al; Thyroid Studies Collaboration. Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: an individual participant data analysis. J Clin Endocrinol Metab. 2014;99(9):3353-3362.
17. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ. 2010;340: c221.
18. Nanchen D, Gussekloo J, Westendorp RG, et al; PROSPER Group. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab. 2012;97 (3):852-861.
19. Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005;165 (21):2467-2472.
20. Imaizumi M, Akahoshi M, Ichimaru S, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004;89(7):3365-3370.
21. Ceresini G, Ceda GP, Lauretani F, et al. Thyroid status and 6-year mortality in elderly people living in amildly iodine-deficient area: the aging in the Chianti Area Study. J AmGeriatr Soc. 2013;61(6): 868-874.
22. Hollowell JG, Staehling NW, FlandersWD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.
23. Goichot B, Sapin R, Schlienger JL. Subclinical hyperthyroidism: considerations in defining the lower limit of the thyrotropin reference interval. Clin Chem. 2009;55(3):420-424.
24. Nevitt MC, Ettinger B, Black DM, et al. The association of radiographically detected vertebral fractures with back pain and function: a prospective study. Ann Intern Med. 1998;128(10):793-800.
25. Helfand M, Balshem H. Principles in Developing and Applying Guidance for Comparing Medical Interventions. Rockville, MD: Agency for Healthcare Research and Quality; 2008.
26. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed April 8, 2015.
27. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
28. Heinze G, Schemper M. A solution to the problem of monotone likelihood in Cox regression. Biometrics. 2001;57(1):114-119.
29. da Costa BR, Juni P. Systematic reviews and meta-analyses of randomized trials: principles and pitfalls. Eur Heart J. 2014;35(47):3336-3345.
30. De Laet C, Kanis JA, Oden A, et al Body mass index as a predictor of fracture risk: ameta-analysis. Osteoporos Int. 2005;16(11):1330-1338.
31. Kanis JA, Johnell O, Oden A, et al Smoking and fracture risk: ameta-analysis. Osteoporos Int. 2005; 16(2):155-162.
32. Drake MT, Murad MH, Mauck KF, et al. Clinical review: risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(6): 1861-1870.
33. Waring AC, Arnold AM, Newman AB, Buzkova P, Hirsch C, Cappola AR. Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab. 2012;97(11):3944-3950.
34. Vittinghoff E, Glidden DV, Shiboski S, McCulloch CE. Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models. New York, NY: Springer; 2005.
35. Schoenfeld D. Chi-squared goodness-of-fit tests for the proportional hazards regression model. Biometrika. 1980;67(1):145-153. doi: 10.1093/biomet/67.1.145.
36. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
37. Rodondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med. 2005;165(21):2460-2466.
38. Boekholdt SM, Titan SM, Wiersinga WM, et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf). 2010;72(3):404-410.
39. Svare A, Nilsen TI, Asvold BO, et al Does thyroid function influence fracture risk? prospective data from the HUNT2 study, Norway. Eur J Endocrinol. 2013;169(6):845-852.
40. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, FrolichM, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292(21):2591-2599.
41. Murphy E, Gluer CC, Reid DM, et al. Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women. J Clin Endocrinol Metab. 2010;95(7):3173-3181.
42. Hofman A, Darwish Murad S, van Duijn CM, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol. 2013;28(11):889-926.
43. Fink HA, Milavetz DL, Palermo L, et al What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J Bone Miner Res. 2005;20(7):1216-1222.
44. Greenspan SL, Greenspan FS. The effect of thyroid hormone on skeletal integrity. Ann Intern Med. 1999;130(9):750-758.
45. Schneider R, Reiners C. The effect of levothyroxine therapy on bone mineral density: a systematic review of the literature. Exp Clin Endocrinol Diabetes. 2003;111(8):455-470.
46. Barrett-Connor E, Weiss TW, McHorney CA, Miller PD, Siris ES. Predictors of falls among postmenopausal women: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int. 2009;20(5):715-722.
47. Brennan MD, Powell C, Kaufman KR, Sun PC, Bahn RS, Nair KS. The impact of overt and subclinical hyperthyroidism on skeletal muscle. Thyroid. 2006;16(4):375-380.
48. Turner MR, Camacho X, Fischer HD, et al. Levothyroxine dose and risk of fractures in older adults: nested case-control study. BMJ. 2011;342: d2238.
49. Egger M, Davey Smith G, Altman DG. Systematic Reviews in Health Care:Meta-analysis in Context. 2nd ed. London, England: BMJ Publishing Group; 2001.
50. Altman DG. Systematic reviews of evaluations of prognostic variables. BMJ. 2001;323(7306):224-228.
51. Walsh JP, Bremner AP, Feddema P, Leedman PJ, Brown SJ, O'Leary P. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab. 2010;95(3):1095-1104.
52. Meyerovitch J, Rotman-Pikielny P, SherfM, Battat E, Levy Y, Surks MI. Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Arch Intern Med. 2007;167(14):1533-1538.
53. Rosario PW. Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study. Clin Endocrinol (Oxf). 2010;72(5):685-688.
54. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf). 1991;34(1):77-83.
55. Bahn RS, Burch HB, Cooper DS, et al Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid. 2011;21(6):593-646. doi: 10.1089/thy.2010.0417.
56. Meier C, Beat M, Guglielmetti M, Christ-Crain M, Staub JJ, Kraenzlin M. Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: a randomized controlled trial. Osteoporos Int. 2004;15(3):209-216.
57. Yonem O, Dokmetas HS, Aslan SM, Erselcan T. Is antithyroid treatment really relevant for young patients with subclinical hyperthyroidism? Endocr J. 2002;49(3):307-314.
58. Buscemi S, Verga S, Cottone S, et al. Favorable clinical heart and bone effects of anti-thyroid drug therapy in endogenous subclinical hyperthyroidism. J Endocrinol Invest. 2007;30(3):230-235.
59. Ross DS. Bone density is not reduced during the short-term administration of levothyroxine to postmenopausal women with subclinical hypothyroidism: a randomized, prospective study. Am J Med. 1993;95(4):385-388.